Vistin Pharma ASA: Mandatory notification of trade

Saga Pure ASA has on 23 August 2024 purchased 300,000 shares in Vistin Pharma ASA at NOK 22,50 per share. After the transaction Saga Pure ASA has a holding of 400,000 shares, corresponding to 0.9 % ownership. Saga Pure ASA is closely associated with board member Øystein Stray Spetalen.

Attachment

• 20240823_Notification of trade_Saga i Vistin

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• JumpCube Launches Free Program to Set Up Claude on AWS and Support AI-Driven Transformation for Businesses in Texas
• How Smart Employers Win Loyal Talent